Apoptosis Inhibitor of Macrophage, Monocyte Chemotactic Protein-1, and C-Reactive Protein Levels Are Increased in Patients with Metabolic Syndrome: A Pilot Study. [electronic resource]
- Metabolic syndrome and related disorders 05 2020
- 197-205 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't